<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02229630</url>
  </required_header>
  <id_info>
    <org_study_id>P130915</org_study_id>
    <secondary_id>IDRCB: 2014-A00640-47</secondary_id>
    <nct_id>NCT02229630</nct_id>
  </id_info>
  <brief_title>Diffusion-weighted Cerebral MRI and Intra Uterine Growth Restriction.</brief_title>
  <acronym>REDIFF</acronym>
  <official_title>Prognostic Value of Diffusion-weighted Cerebral MRI in Prenatal Evaluation of Foetuses With Intra Uterine Growth Restriction.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the apparent diffusion coefficient in the frontal
      lobe of foetuses with intra-uterine growth restriction and poor neonatal outcome compared
      with foetuses with intra-uterine growth restriction and a good neonatal outcome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Intra-uterine growth restriction is associated with an increased risk of perinatal
      morbimortality. The objective of foetal monitoring is to assess foetal growth, foetal
      well-being and to evaluate ability to adapt to chronic hypoxia.

      The primary objective in antenatal care is to ischemic cerebral lesions. However, there is
      currently no relevant prenatal exam predictive for the risk of such lesions.

      Foetal cerebral MRI could highlight changes in Apparent Diffusion Coefficient (ADC) in some
      frontal cerebral territories in foetuses with intra-uterine growth restriction and poor
      neonatal outcome.

      These changes could be associated with a transient cerebral ischemia. The study of ADC could
      be a useful tool in the prognostic evaluation of these foetuses.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 11, 2015</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Actual">October 29, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Poor neonatal status</measure>
    <time_frame>At birth</time_frame>
    <description>Neonatal death; Apgar score &lt; 7 at 5 min, immediate transfer to neonatal resuscitation unit</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Poor neonatal status</measure>
    <time_frame>until 30 days of life</time_frame>
    <description>Necrositing enterocolitis with need for surgical intervention; convulsions; intraventricular haemorrhage (type I to IV); periventricular leukomalacia (diagnosed by MRI); transfer to neonatal intensive care unit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal status at neonatology unit discharge</measure>
    <time_frame>up to 20 weeks</time_frame>
    <description>Neurological status: normal / abnormal; need in O2: Yes/No</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurological development</measure>
    <time_frame>At 2 years of age (adjusted age)</time_frame>
    <description>Age and stages questionnaire (ASQ)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">82</enrollment>
  <condition>Pregnant Women With Foetuses Presenting With Intra-uterine Growth Restriction</condition>
  <arm_group>
    <arm_group_label>Pregnant women</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Foetuses with intra-uterine growth restriction, between 28 and 32 weeks of gestation, with an estimated foetal weight &lt; 5th percentile (Hadlock calculator)</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Pregnant women with intra-uterine growth restricted Foetuses</intervention_name>
    <description>Diffusion-weighted cerebral MRI before 32 weeks of gestation</description>
    <arm_group_label>Pregnant women</arm_group_label>
    <other_name>cerebral MRI</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  single pregnancy between 28 and 32 weeks of gestation

          -  estimated foetal weight &lt; 5th percentile

          -  no foetal abnormality

          -  woman aged &gt; 18 years of age, covered by the French social security system, and
             speaking French language

          -  agreeing to participate upon written informed consent

        Exclusion Criteria:

          -  multiple pregnancies

          -  foetal malformation or karyotype abnormalities

          -  infectious foetopathy

          -  refusal to participate
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Marie Jouannic, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôpital Armand Trousseau</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Thornton JG, Hornbuckle J, Vail A, Spiegelhalter DJ, Levene M; GRIT study group. Infant wellbeing at 2 years of age in the Growth Restriction Intervention Trial (GRIT): multicentred randomised controlled trial. Lancet. 2004 Aug 7-13;364(9433):513-20.</citation>
    <PMID>15302194</PMID>
  </reference>
  <reference>
    <citation>Boers KE, Vijgen SM, Bijlenga D, van der Post JA, Bekedam DJ, Kwee A, van der Salm PC, van Pampus MG, Spaanderman ME, de Boer K, Duvekot JJ, Bremer HA, Hasaart TH, Delemarre FM, Bloemenkamp KW, van Meir CA, Willekes C, Wijnen EJ, Rijken M, le Cessie S, Roumen FJ, Thornton JG, van Lith JM, Mol BW, Scherjon SA; DIGITAT study group. Induction versus expectant monitoring for intrauterine growth restriction at term: randomised equivalence trial (DIGITAT). BMJ. 2010 Dec 21;341:c7087. doi: 10.1136/bmj.c7087.</citation>
    <PMID>21177352</PMID>
  </reference>
  <reference>
    <citation>Boyer AC, Gonçalves LF, Lee W, Shetty A, Holman A, Yeo L, Romero R. Magnetic resonance diffusion-weighted imaging: reproducibility of regional apparent diffusion coefficients for the normal fetal brain. Ultrasound Obstet Gynecol. 2013 Feb;41(2):190-7. doi: 10.1002/uog.11219. Epub 2013 Jan 3.</citation>
    <PMID>22744761</PMID>
  </reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 17, 2014</study_first_submitted>
  <study_first_submitted_qc>August 29, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 1, 2014</study_first_posted>
  <last_update_submitted>January 4, 2018</last_update_submitted>
  <last_update_submitted_qc>January 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>intra-uterine growth restriction</keyword>
  <keyword>MRI</keyword>
  <keyword>apparent diffusion coefficient</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fetal Growth Retardation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

